<code id='B864701626'></code><style id='B864701626'></style>
    • <acronym id='B864701626'></acronym>
      <center id='B864701626'><center id='B864701626'><tfoot id='B864701626'></tfoot></center><abbr id='B864701626'><dir id='B864701626'><tfoot id='B864701626'></tfoot><noframes id='B864701626'>

    • <optgroup id='B864701626'><strike id='B864701626'><sup id='B864701626'></sup></strike><code id='B864701626'></code></optgroup>
        1. <b id='B864701626'><label id='B864701626'><select id='B864701626'><dt id='B864701626'><span id='B864701626'></span></dt></select></label></b><u id='B864701626'></u>
          <i id='B864701626'><strike id='B864701626'><tt id='B864701626'><pre id='B864701626'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:38111
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          A biotech analyst on neuroscience, placebo effect, not over
          A biotech analyst on neuroscience, placebo effect, not over

          PaulMatteis(right),in2017withthen-colleaguesSeamusFernandez(farleft)GeoffreyPorges.AlexHogan/STATNEW

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Drastic changes should bring profitability, startup health insurers say

          AdobeStartupinsurersOscarHealth,BrightHealth,andCloverHealthhavehemorrhagedmoneysincegoingpublicwith